Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

2articles mentioning treatments

11treatment mentions

1distinct treatments extracted

0%of mentions human-reviewed

Active filtersEntity: csDMARDs ×

csDMARDs

This treatment is selected. Its supporting articles are shown below.

Articles mentioning csDMARDs

2 articles · page 1 of 1

PT6:05 Susceptibility to pneumocystis jirovecii pneumonia and predisposing disease-modifying antirheumatic drugs in systemic lupus erythematosus: a cohort study from the largest health care system in Taiwan

lupusscimed · abstract · 2026-03-01 · 10 matching annotations

86.8%

csDMARDs immunosuppressants conventional synthetic disease-modifying antirheumatic drugs systemic lupus erythematosus leflunomide cyclosporin

…of the disease characteristics that had warranted initiation of csDMARDs, we used Directed Acyclic Graphs to construct a causal model fo…

LBA:01:31 Clinical spectrum, genetic background, and outcomes of pediatric monogenic lupus: a single-center cohort study

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

76.3%

JAK inhibitors biologic therapies csDMARDs hydroxychloroquine monogenic lupus rituximab intensive care interventions lupus tertiary pediatric rheumatology center lupus-like+1 more

…e-modifying antirheumatic drugs (csDMARDs), biologic therapies, JAK inhibitors, and intensive care interventions, were recorded. Disease activ…